Literature DB >> 4346813

A kindred with familial glucocorticoid suppressible aldosteronism.

G S Giebink, R W Gotlin, E G Biglieri, F H Katz.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4346813     DOI： 10.1210/jcem-36-4-715

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Variation of phenotype in patients with glucocorticoid remediable aldosteronism.

Authors:  L J Gates; A A MacConnachie; R P Lifton; N E Haites; N Benjamin
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

Review 2.  Glucocorticoid-remediable aldosteronism.

Authors:  G H Williams; R G Dluhy
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

3.  Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension.

Authors:  W Rauh; L S Levine; K Gottesdiener; M I New
Journal:  Klin Wochenschr       Date:  1978

4.  Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.

Authors:  F Fallo; N Sonino; M Boscaro; D Armanini; F Mantero; H G Dörr; D Knorr; U Kuhnle
Journal:  Klin Wochenschr       Date:  1987-05-15

5.  The diagnosis of Liddle syndrome by identification of a mutation in the beta subunit of the epithelial sodium channel.

Authors:  S N Jackson; B Williams; P Houtman; R C Trembath
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.